Development of a Modeling Framework to Simulate Efficacy Endpoints for Motesanib in Thyroid Cancer Patients Publication Development of a Modeling Framework to Simulate Efficacy Endpoints for Motesanib in Thyroid Cancer Patients To develop a modeling framework that simulates clinical endpoints (objective response rate and progression-free survival)…CertaraNovember 1, 2010
Population Pharmacokinetic/Pharmacodynamic Modeling for the Time Course of Tumor Shrinkage by Motesanib in Thyroid Cancer Patients Publication Population Pharmacokinetic/Pharmacodynamic Modeling for the Time Course of Tumor Shrinkage by Motesanib in Thyroid Cancer Patients To develop a population pharmacokinetic/pharmacodynamic model describing the relationship between motesanib exposure and tumor response…CertaraNovember 1, 2010
Randomised, Parallel-group, Multicenter, Multinational Phase 2 Study Comparing Edoxaban, an Oral Factor Xa Inhibitor, with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Publication Randomised, Parallel-group, Multicenter, Multinational Phase 2 Study Comparing Edoxaban, an Oral Factor Xa Inhibitor, with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation The primary objective of this study was to compare the safety of four fixed-dose regimens…CertaraSeptember 10, 2010
A Pharmacokinetic/Pharmacodynamic Model for Cardiovascular Safety Assessment of R1551 Publication A Pharmacokinetic/Pharmacodynamic Model for Cardiovascular Safety Assessment of R1551 Pharmacokinetic-pharmacodynamic relationships are crucial in understanding a drug's arrhythmogenic potential. Models assist to quantitatively relate…CertaraAugust 21, 2010
A Modeling and Simulation Framework to Support Early Clinical Drug Development Decisions in Oncology Publication A Modeling and Simulation Framework to Support Early Clinical Drug Development Decisions in Oncology CertaraJuly 13, 2010
Relationship Between Exposure to Sunitinib and Efficacy and Tolerability Endpoints in Patients with Cancer: Results of a Pharmacokinetic/Pharmacodynamic Meta-analysis Publication Relationship Between Exposure to Sunitinib and Efficacy and Tolerability Endpoints in Patients with Cancer: Results of a Pharmacokinetic/Pharmacodynamic Meta-analysis In this pharmacokinetic/pharmacodynamic meta-analysis, we investigated relationships between clinical endpoints and sunitinib exposure in patients…CertaraJuly 1, 2010
Pharmacology and Safety of Glycerol Phenylbutyrate in Healthy Adults and Adults with Cirrhosis Publication Pharmacology and Safety of Glycerol Phenylbutyrate in Healthy Adults and Adults with Cirrhosis Phenylbutyric acid (PBA), which is approved for treatment of urea cycle disorders (UCDs) as sodium…CertaraJune 1, 2010
Under-reporting of Venous and Arterial Thrombotic Events in Randomized Clinical Trials: A Meta-analysis Publication Under-reporting of Venous and Arterial Thrombotic Events in Randomized Clinical Trials: A Meta-analysis For the detection of unwanted outcomes of new interventions, physicians rely on adverse event reporting.…CertaraMarch 1, 2010
Detection of Lymph Node Metastases by Gadolinium-enhanced Magnetic Resonance Imaging: Systematic Review and Meta-analysis Publication Detection of Lymph Node Metastases by Gadolinium-enhanced Magnetic Resonance Imaging: Systematic Review and Meta-analysis Gadolinium-based contrast agents are used with magnetic resonance imaging (MRI) to highlight tumor vascularity in…CertaraFebruary 24, 2010
The Use of Biosimulation in the Design of a Novel Multilevel Weight Loss Maintenance Program for Overweight Children Publication The Use of Biosimulation in the Design of a Novel Multilevel Weight Loss Maintenance Program for Overweight Children Weight loss outcomes achieved through conventional behavior change interventions are prone to deterioration over time.…CertaraFebruary 18, 2010